Anti-MEGF9 Antibody

Western blot analysis of MEGF9 expression in A549 (A), HepG2 (B), LO2 (C), PC12 (D) whole cell lysates. (Predicted band size: 62 kD; Observed band size: 68 kD)
Immunohistochemical analysis of MEGF9 staining in human liver cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

Product Information
Application Applications Legend: E=ELISA WB=Western Blotting IHC=Immunohistochemistry IHC-P=Immunohistochemistry (Paraffin) IP=Immunoprecipitation IF=Immunofluorescence IC=Immunochemistry ICC=Immunocytochemistry FC=Flow Cytometry DB=Dot Blot	WB, IHC
Primary Accession	Q9H1U4
Reactivity	Human, Rat, Mk
Host	Rabbit
Clonality	Polyclonal
Calculated MW	62984 Da

Additional Information
Gene ID	1955
Other Names	EGFL5; KIAA0818; Multiple epidermal growth factor-like domains protein 9; Multiple EGF-like domains protein 9; Epidermal growth factor-like protein 5; EGF-like protein 5
Target/Specificity	KLH-conjugated synthetic peptide encompassing a sequence within the center region of human MEGF9. The exact sequence is proprietary.
Dilution	WB~~WB (1/500 - 1/1000) IHC~~1:100~500
Format	Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Storage	Store at -20 °C.Stable for 12 months from date of receipt